OP64 Pattern of Failure after Stereotactic Body Radiotherapy (SBRT) for Liver Metastases: Impact of Local Control
OP63 Stereotactic Body Radiation Therapy (SBRT) in Patients with Hepatocellular Carcinoma (HCC): A Monocenter Experience
OP62 Impact of Stereotactic Body Radiation Therapy on the Prognosis of Unresectable Pancreatic Cancer. Clinical Results and Prognostic Factors on 142 Patients
OP61 Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Patients with Initially Inoperable Adenocarcinoma of the Pancreas
OP48 Robotic SBRT in Treatment of Intermediate Unfavorable to Very High-risk Prostate Cancer: A Single Centre Experience
OP47 Comparison of Two Protocols of Robotic Stereotactic Body Radiotherapy Used in Prostate Cancer Patients in a Mono-institutional Experience
OP84 Stereotactic Body Radiotherapy (SBRT) in Oligomestatic / Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity
OP44 1.5T MR-guided Daily-adapted Stereotactic Body Radiotherapy for Prostate Re-irradiation: A Preliminary Report of Toxicity and Clinical Outcomes
OP43 Preliminary Report of Toxicity and Quality of Life of the First 100 Patients Treated with 1.5T MR-guided Stereotactic Body Radiotherapy for Prostate Cancer
